HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

nebacumab

withdrawn from clinical trials for treatment of septicemia after excess mortality; monoclonal antiendotoxin agent; USAN lists 138661-01-5 as RN for nebacumab; MW about 1000 kDa
Also Known As:
Centoxin; HA-1A; HA-1A monoclonal antibody; septomonab
Networked: 48 relevant articles (5 outcomes, 14 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Related Diseases

1. Sepsis (Septicemia)
2. Systemic Inflammatory Response Syndrome (Sepsis Syndrome)
3. Bacteremia
4. Shock
5. Infection

Related Drugs and Biologics

1. Lipid A
2. Monoclonal Antibodies
3. nebacumab
4. Oxygen
5. Methylprednisolone
6. Immunoglobulin M (IgM)
7. Antibodies
8. bactericidal permeability increasing protein

Related Therapies and Procedures

1. Immunotherapy
2. Intensive Care (Surgical Intensive Care)
3. Critical Care